Oral Octreotide Shows Promise as Alternative to Injections for Acromegaly

Many patients with acromegaly may do as well on oral octreotide treatment as they do on injectable somatostatin receptor ligands, an industry-sponsored phase 3 trial suggests.
Reuters Health Information

source https://www.medscape.com/viewarticle/966233?src=rss